⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Taisho Pharmaceutical Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Taisho Pharmaceutical Co., Ltd.
↗Tokyo, Japan
Taisho Pharmaceutical is a prominent Japanese pharmaceutical company founded in 1912, recognized as a leader in the domestic over-the-counter (OTC) market. The company operates through two primary segments: Self-Medication (OTC drugs, health foods, and skincare) and Prescription Pharmaceuticals.
Beyond its strong consumer health presence with brands like Lipovitan, Pabron, and RiUP, Taisho is actively engaged in prescription drug R&D, focusing on therapeutic areas such as oncology, central nervous system (CNS) disorders, and anti-aging. The company has expanded its global footprint through strategic acquisitions, including the French manufacturer UPSA, and maintains various international partnerships to drive innovation and market reach.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:OTC and Prescription Pharmaceuticals
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$2B-$3B
Founded:1912
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Commercial
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Taisho Pharmaceutical Holdings Co., Ltd.
Subsidiaries:Taisho Pharma Co., Ltd., Biofermin Pharmaceutical Co., Ltd., UPSA
Key Partnerships:Abbott (historical), DHG Pharma (strategic partner), Eisai (marketing rights transfer)
COMPETITION
Position:Leader
Competitors:Takeda Pharmaceutical, Daiichi Sankyo, Eisai, Otsuka Pharmaceutical
LEADERSHIP
Key Executives:
Akira Uehara - President and CEO
Shigeru Uehara - Executive Vice President
LINKS
Website:taisho.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Taisho Pharmaceutical Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.